Harprit Singh: Future – Ready Hospitals Will Have Apheresis Hubs, Not Just Dialysis Units
Harprit Singh, Associate Director at Transfusion Technologies, Therapies, Solutions and Consultant in Transfusion Medicine at Alchemist Hospital, shared a post on LinkedIn:
“Future – Ready Hospitals Will Have Apheresis Hubs – Not Just Dialysis Units
Most hospitals don’t have an apheresis problem.
They have a utilization problem.
In multiple institutions I’ve worked with, the pattern is consistent:
- Apheresis machines exist.
- Clinical expertise exists.
- But activation pathways don’t.
The result?
- Delayed therapeutic plasma exchange (TPE)
- Underutilized apheresis services
- Missed integration with solid organ and bone marrow transplant (BMT) and oncology
- Higher ICU burden and avoidable costs
This is where strategy changes everything.
Hospitals that build Clinical Apheresis Hubs – not fragmented services – unlock the following:
- Faster intervention in critical care
- Seamless transplant and cellular therapy workflows
- Reduced ICU dependency
High-value, predictable clinical revenue
Because an Apheresis Hub is not equipment.
It is a clinical plus operational plus financial system.
Protocols define speed
Ownership defines utilisation.
The question is no longer:
‘Do we have apheresis?’
It is:
‘Is it integrated into how we deliver care?’
For COs and administrators, this is where transfusion medicine becomes strategy – not support.
A practical starting point:
Map 3 things
Who triggers apheresis?
How fast can it be activated?
How often is iused?
An open question:
What is the single biggest barrier to apheresis utilisation in your institution today?”
Stay updated with Hemostasis Today.
-
Aug 22, 2026, 11:36Bernardo Gindri: How platelets Influence Cancer Progression
-
Aug 22, 2026, 11:34Nick Gehrig: Extending Platelet Shelf Life to Strengthen Blood Supply
-
Aug 22, 2026, 11:14Lei Yu: New Guidance for Acute Pulmonary Embolism in 2026
-
Aug 22, 2026, 11:01Neeraj Songara: Shelf-Stable Synthetic Blood – The Future of Emergency Transfusion?
-
Aug 22, 2026, 10:41Mike R.։ VTE Thrombectomy – Defining What Success Really Means
-
Aug 22, 2026, 10:28Steven Meier: What Happens During PRP Therapy?
-
Aug 22, 2026, 10:05Ralf Ludwig: When a Promising Biomarker Falls Short
-
Aug 22, 2026, 09:33Mary Cushman: What Causes PE to Happen in People with DVT?
-
Aug 22, 2026, 07:45Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation